Literature DB >> 24111732

Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification.

Jaume Ordi1, Christine Bergeron, David Hardisson, W Glenn McCluggage, Harry Hollema, Ana Felix, Robert A Soslow, Esther Oliva, Fattaneh A Tavassoli, Isabel Alvarado-Cabrero, Michael Wells, Francisco F Nogales.   

Abstract

AIMS: To compare the reproducibility of the current (2003) World Health Organization (WHO), endometrial intraepithelial neoplasia (EIN) and European Working Group (EWG) classifications of endometrial endometrioid proliferations. METHODS AND
RESULTS: Nine expert gynaecological pathologists from Europe and North America reviewed 198 endometrial biopsy/curettage specimens originally diagnosed as low-grade lesions. All observers were asked to classify the cases by using the categories described in each scheme: six for WHO, four for EIN, and three for EWG. The results were evaluated by kappa statistics for more than two observations. The analysis was repeated using only two major categories (benign versus atypical/carcinoma). Both the WHO and EIN classifications showed poor interobserver agreement (κ = 0.337 and κ = 0.419, respectively), whereas the EWG classification showed moderate agreement (κ = 0.530). Full agreement between pathologists occurred in only 28% for the WHO classification, 39% for the EIN classification, and 59% for the EWG classification. With only two diagnostic categories, kappa values increased in all classifications, but only the EWG classification reached a substantial level of agreement (κ = 0.621); similarly, full agreement among all pathologists increased to 70% for the WHO classification, 69% for the EIN classification, and 72% for the EWG classification.
CONCLUSIONS: A two-tier classification of endometrial endometrioid proliferative lesions improves reproducibility, and should be considered for the diagnosis of endometrial biopsy/curettage specimens.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  endometrial carcinoma; endometrial hyperplasia; interobserver variability

Mesh:

Year:  2013        PMID: 24111732     DOI: 10.1111/his.12249

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

Review 1.  Pathophysiology of heavy menstrual bleeding.

Authors:  Dharani K Hapangama; Judith N Bulmer
Journal:  Womens Health (Lond)       Date:  2015-12-23

2.  Hypermethylated CDO1 and ZNF454 in Cytological Specimens as Screening Biomarkers for Endometrial Cancer.

Authors:  Lei Wang; Lanlan Dong; Jun Xu; Lin Guo; Yiran Wang; Kangkang Wan; Wei Jing; Lanbo Zhao; Xue Feng; Kailu Zhang; Miao Guo; Yuliang Zou; Lianglu Zhang; Qiling Li
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

Review 3.  [Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].

Authors:  F Kommoss; S F Lax
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

4.  Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors.

Authors:  Mitzi Aguilar; He Zhang; Musi Zhang; Brandi Cantarell; Subhransu S Sahoo; Hao-Dong Li; Ileana C Cuevas; Jayanthi Lea; David S Miller; Hao Chen; Wenxin Zheng; Jeffrey Gagan; Elena Lucas; Diego H Castrillon
Journal:  J Pathol       Date:  2021-03-09       Impact factor: 7.996

Review 5.  New classification system of endometrial hyperplasia WHO 2014 and its clinical implications.

Authors:  Katarzyna Sobczuk; Anna Sobczuk
Journal:  Prz Menopauzalny       Date:  2017-10-12

6.  Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis.

Authors:  Michelle T Doherty; Omolara B Sanni; Helen G Coleman; Chris R Cardwell; W Glenn McCluggage; Declan Quinn; James Wylie; Úna C McMenamin
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

7.  Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.

Authors:  Mitzi Aguilar; Hao Chen; Glorimar Rivera-Colon; Shuang Niu; Kelley Carrick; Katja Gwin; Ileana C Cuevas; Subhransu S Sahoo; Hao-Dong Li; Song Zhang; Wenxin Zheng; Elena Lucas; Diego H Castrillon
Journal:  Am J Surg Pathol       Date:  2022-03-01       Impact factor: 6.394

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.